Glucocorticosteroid therapy for multiple sclerosis: A critical review
Authors:
- Donald E GoodkinDGDonald E Goodkin
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 160 (1) , 16-25
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Mechanisms of Immune Injury in Multiple SclerosisBrain Pathology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Double-Blind Trial of Dexamethasone versus Methylprednisolone in Multiple Sclerosis Acute RelapsesEuropean Neurology, 1994
- Anti-inflammatory actions of steroids: molecular mechanismsTrends in Pharmacological Sciences, 1993
- Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Glucocorticoid effects on the production and actions of immune cytokinesJournal of Steroid Biochemistry, 1988
- Suppression of phagocytosis by dexamethasone in macrophage cultures: Inability of arachidonic acid, indomethacin, and nordihydroguaiaretic acid to reverse the inhibitory response mediated by a steroid-inducible factorInternational Journal of Immunopharmacology, 1985
- “Bolus” methylprednisolone versus ACTH in the treatment of multiple sclerosisThe Italian Journal of Neurological Sciences, 1983
- Comparison of the Effector Cells in Human Spontaneous Cellular Cytotoxicity and Antibody‐Dependent Cellular Cytotoxicity: Differential Sensitivity of Effector Cells to in Vivo and in Vitro CorticosteroidsScandinavian Journal of Immunology, 1978
- CORTICOTROPHIN TREATMENT IN MULTIPLE SCLEROSISActa Neurologica Scandinavica, 1968